Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study. by Carroccio, A. et al.
Carroccio et al. BMC Medicine 2014, 12:230
http://www.biomedcentral.com/1741-7015/12/230RESEARCH ARTICLE Open AccessRisk of low bone mineral density and low body
mass index in patients with non-celiac wheat-
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Girolamo Geraci3†, Ignazio Brusca5†, Aurelio Seidita1†, Floriana Adragna1†, Miriam Carta1† and Pasquale Mansueto1†Abstract
Background: Non-celiac gluten sensitivity (NCGS) or ‘wheat sensitivity’ (NCWS) is included in the spectrum of
gluten-related disorders. No data are available on the prevalence of low bone mass density (BMD) in NCWS. Our
study aims to evaluate the prevalence of low BMD in NCWS patients and search for correlations with other clinical
characteristics.
Methods: This prospective observation study included 75 NCWS patients (63 women; median age 36 years) with
irritable bowel syndrome (IBS)-like symptoms, 65 IBS and 50 celiac controls. Patients were recruited at two Internal
Medicine Departments. Elimination diet and double-blind placebo controlled (DBPC) wheat challenge proved the
NCWS diagnosis. All subjects underwent BMD assessment by Dual Energy X-Ray Absorptiometry (DXA), duodenal
histology, HLA DQ typing, body mass index (BMI) evaluation and assessment for daily calcium intake.
Results: DBPC cow's milk proteins challenge showed that 30 of the 75 NCWS patients suffered from multiple food
sensitivity. Osteopenia and osteoporosis frequency increased from IBS to NCWS and to celiac disease (CD)
(P <0.0001). Thirty-five NCWS patients (46.6%) showed osteopenia or osteoporosis. Low BMD was related to low BMI
and multiple food sensitivity. Values of daily dietary calcium intake in NCWS patients were significantly lower than
in IBS controls.
Conclusions: An elevated frequency of bone mass loss in NCWS patients was found; this was related to low BMI
and was more frequent in patients with NCWS associated with other food sensitivity. A low daily intake of dietary
calcium was observed in patients with NCWS.
Keywords: Non-celiac wheat sensitivity, Multiple food allergy, Body mass index, OsteoporosisBackground
Celiac disease (CD) has been reported to increase the
risk of osteoporosis, with a resulting augmented risk of
fractures [1]. More recently, it has been reported that a
consistent percentage of the general population consider
themselves to be suffering from problems caused by
wheat and/or gluten ingestion, even though they do not
have CD or wheat allergy [2,3]. This clinical condition* Correspondence: acarroccio@hotmail.com
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unless otherwise stated.has been named Non-Celiac Gluten Sensitivity’ (NCGS).
In a previous paper [4] we suggested the term ‘Non-Ce-
liac Wheat Sensitivity’ (NCWS), since it is not known
what component of wheat causes the symptoms in
NCGS patients, and we also showed that these patients
had a high frequency of coexistent multiple food hyper-
sensitivity [4]. That previous study also showed a per-
centage of NCWS patients had weight loss and anemia:
whether these depended on the intestinal malabsorption
or not remains unclear.
As yet no data are available on the presence and
prevalence of low bone mass density (BMD) in NCWS
patients. The aims of the present study were: 1) to inves-
tigate the prevalence of low BMD in NCWS patients;ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and other clinical characteristics, in particular the body
mass index (BMI), of NCWS patients.Methods
Study population
This prospective study included consecutive adult pa-
tients with an irritable bowel syndrome (IBS)-like clin-
ical presentation, according to Rome II criteria [5], and a
definitive diagnosis of NCWS. The patients were re-
cruited at the Internal Medicine Department of the
University Hospital of Palermo and at the Internal Medi-
cine Department of the Hospital of Sciacca (Italy),
between July 2011 and July 2013. Most of the patients
were referred due to intestinal symptoms with onset
after wheat ingestion. None of them were included in
previous published studies.
NCWS diagnosis was made according to the recently
proposed criteria [2] (see Additional file 1). Both the CD
specific serum antibodies and the duodenal histology
were evaluated on a diet containing at least 100 grams
of wheat per day, for at least three months. Furthermore,
according to our experience [4], all patients met the
following adjunctive inclusion criteria: 1) resolution of
the IBS symptoms on a standard elimination diet exclud-
ing wheat, cow’s milk, egg, tomato, chocolate and other
self-reported food(s) causing symptoms; and 2) symptom
reappearance on double-blind placebo-controlled (DBPC)
wheat challenge. DBPC cow’s milk protein (CMP) challenge
and other ‘open’ food challenges were also performed in all
cases [4].
Exclusion criteria were: 1) self-exclusion of wheat from
the diet and refusal to reintroduce it, before entering the
study; 2) nervous system disease, major psychiatric
disorder; 3) hyperparathyroidism, Cushing’s syndrome,
kidney disease and other ‘organic’ gastrointestinal disor-
ders; 4) physical impairment limiting physical activity; 5)
menopause; and 6) steroid and sex steroid therapy,
hormone replacement therapy or ovariectomy.
Fifty sex- and age-matched subjects with CD and sixty-
five suffering from IBS unrelated to NCWS or other food
‘intolerance,’ diagnosed according to standard criteria
during the same study period, were chosen at random
(randomized by computer generated method among the
patients with a new CD or IBS diagnosis posed during the
same study period) and enrolled as control groups. The
same exclusion criteria used for the NCWS patients were
applied to the control groups.Methods
On entering the study all patients underwent serum assays
and HLA-DQ typing for CD diagnosis (see Additional file
1). Specific IgE (RAST) and/or skin prick tests for foodallergens were performed on all patients, as previously de-
scribed [4].
Duodenal histology
Four to six biopsy specimens were obtained from the
bulb and the second duodenal portion during gastroduo-
denoscopy, performed when the patients were on a
wheat-containing diet. The slides were stained with
hematoxylin and eosin and graded according to the ori-
ginal modified Marsh classification [6]. The number of
intraepithelial lymphocytes (IELs) per 100 villous epithe-
lial cells was assessed by immunohistochemical staining.
The upper limit of the reference interval in our labora-
tory was 25 IEL/100 epithelial cells. The number of eo-
sinophils (EOS) per high-power fields (HPFs, 40 X) was
also assessed; the upper limit of the reference interval in
our laboratory was 60 EOS/10 HPFs.
Elimination diet and double-blind placebo-controlled
challenge method
On entering the study all patients commenced a standard
elimination diet, with the exclusion of wheat, cow’s milk,
eggs, tomato and chocolate [4]. Patients self-reporting food
hypersensitivity were also asked to avoid ingestion and/or
contact with the food(s) causing symptoms. After four
weeks on the elimination diet they underwent DBPC wheat
challenges, as previously described [4] (see Additional
file 1). During all phases of the study, including the chal-
lenge period, the severity of symptoms was recorded: the
patients completed a 100 mm visual analog scale (VAS),
with 0 representing no symptoms, which assessed overall
symptoms and the specific symptoms they each reported.
DBPC challenge for CMPs was performed using an identi-
cal method [4], at least four weeks before or after wheat
challenge and when the VAS score was <10, on the elimin-
ation diet. The challenges were stopped when clinical re-
actions occurred (increase in VAS score >30) for at least
two consecutive days (onset of abdominal discomfort or
pain, associated with a change in stool frequency and/or
appearance). The challenges were considered positive if
the same symptoms which had been initially present reap-
peared after their disappearance on the elimination diet.
Other laboratory examinations
The nutritional status of each patient was defined at
diagnosis by measuring the following laboratory indices:
hemoglobin, serum albumin and triglycerides.
Bone mineral density assessment
BMD was assessed at baseline by Dual Energy X-Ray
Absorptiometry (DXA), using a QDR Discovery Hologic
DXA in the femoral neck and in the lumbar spine by
total body DXA. For each scan, BMD (expressed as ab-
solute values in g/cm2) and T-scores were recorded (for
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the lumbar spine of ten healthy volunteers were per-
formed to evaluate the in vivo precision of the absorpti-
ometer. The average coefficient of variation was 2.1%.
Physical examination and dietary assessment
At the start of the study, the BMI of all participants was
recorded. The subjects also filled in a health and lifestyle
questionnaire considering menarche, medical history
and lifestyle habits (including physical activity, smoking
and elimination diet, that is, wheat and other foods).
The subjects also received a previously validated dietary
form containing a printed list of the most common
foods [7] (for details see Additional file 1). Final forms
were analyzed using a computerized database and cal-
cium intake was calculated using a nutrient composition
database [8].
Statistical analysis
Data were expressed as mean ± standard deviation (SD)
when the distribution was Gaussian and differences were
calculated using Student’s t-test. Otherwise, data were
expressed as median and range, and analyzed with the
Kruskall Wallis test and with the Mann–Whitney U test.Table 1 Clinical characteristics of the NCWS patient group, co
IBS unrelated to NCWS and of CD patients
Variables NCWS Patients IBS Pa
(Number = 75) (Numb
Sex 12 M, 63 F 10 M,
Age range (median) 20 to 49 years (36 years) 19 to
IBS type
Diarrhea 45 (60%) 36 (55
Constipation 7 (9%) 7 (11%
Alternate bowel movements 23 (31%) 22 (34
Symptom duration median (range) 5 years (1 to 30 years) 4 year
Weight loss 24/75 (29%) 3/65 (4
Anemia (Hb <12 g/dl) 12/75 (16%) 4/65 (6
Family history of CD 18/75 (24%) 0/65 (0
Coexistent atopy 23/75 (30%) 6/65 (9
Weight loss was considered when the patients reported a loss >10% of body weigh
first-degree relative. Atopic diseases were: rhinitis, conjunctivitis, bronchial asthma,
bowel syndrome; M, male; NCGS, non-celiac gluten sensitivity; NCWS, non-celiac whFisher’s exact and Mantel-Haenszel tests, Pearson’s cor-
relation and Spearman's rank correlation were used
where appropriate. An analysis of variance (ANOVA)
test was performed to evaluate the BMD differences be-
tween the three study groups; post hoc analysis and com-
parison between two groups was performed by means of
the Bonferroni test. Multiple regression analysis was per-
formed to evaluate the association between the presence
of osteopenia and osteoporosis with the other clinical
variables evaluated. P <0.05 was considered significant.
All analyses were performed using the SPSS software
package (version 16.0; Chicago, IL, USA).
The study was approved by the local Ethics Committee
of the University Hospital of Palermo, and informed
consent was obtained from all subjects.
Results
During the study period, 80 patients fulfilled the inclu-
sion criteria, but 5 of them refused to undergo DXA and
were excluded (see Additional file 2). The 75 patients in-
cluded showed IBS-like symptoms on entering the study,
which disappeared completely on the elimination diet
and reappeared on DBPC wheat-challenge (VAS score
increase >30) (see Additional file 3). Table 1 provides thempared to the control group composed of patients with
tients CD Patients P value
er = 65) (Number = 50)
55 F 8 M, 42 F n.s.
50 years (35 years) 20 to 50 years (35 years) n.s.
%) 20 ‘typical’
) 30 ‘atypical’ n.s.
%)
s (0.5 to 20 years) 4 years (0.5 to 10 years) n.s.
%) 15/50 (30%) NCGS vs. IBS 0.0003
CD vs. IBS 0.0001
CD vs. NCGS n.s.
%) 25/50 (50%) NCGS vs. IBS 0.02
CD vs. IBS 0.0001
CD vs. NCGS 0.01
%) 10/50 (20%) NCGS vs. IBS 0.0002
CD vs. IBS 0.001
CD vs. NCGS n.s.
.5%) 10/50 (20%) NCGS vs. IBS 0.01
CD vs. IBS n.s.
CD vs. NCGS n.s.
t during the previous year. Family history of CD indicates a CD diagnosis in a
atopic dermatitis. CD, celiac disease; F, female; Hb, hemoglobin; IBS, irritable
eat sensitivity; n.s., not significant; vs., versus.
Figure 1 Individual and mean ±95% c.i. (bars) values of lumbar
(a) and femoral (b) BMD in the three study groups, expressed
in absolute values (g/cm2). BMD, bone mass density; c.i.,
confidence interval.
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pared to the control groups. NCWS patients had higher
frequencies of weight loss, anemia (90% had iron defi-
ciency anemia), coexistent atopic diseases and family
history of CD than IBS controls.
According to the results of the DBPC challenge with
CMP, 30 of the 75 NCWS patients were found to have
multiple food sensitivity (NCWS plus CMP sensitivity).
These 30 patients were asymptomatic on the elimination
diet and experienced IBS symptoms again on CMP chal-
lenge. Moreover, eight of these thirty patients experienced
IBS-like symptoms after open challenges with egg (four
cases), tomato (three cases) or chocolate (two cases).
HLA DQ2 or DQ8 haplotypes were present in 31 of 75
(41%) NCWS patients. The duodenal histology showed
normal villi but a high number of IEL in the mucosa
(Marsh 1) in 39 NCWS patients (52%), whereas the
remaining 36 NCWS patients had completely normal mu-
cosa (Marsh 0); an eosinophil infiltrate was observed in 24
of the 75 (32%) NCWS patients.
Figure 1 shows the individual values of BMD in the
three study groups. NCWS patients had a significantly
lower BMD than IBS controls both at the lumbar spine
and at the femoral neck (P <0.0001). The patients suffering
from CD showed a significantly lower BMD than NCWS
patients and IBS controls both at the lumbar spine
(ANOVA: F = 8.7; P <0.0001; Bonferroni P <0.0001) and at
the femoral neck (ANOVA: F = 6.7; P <0.002; Bonferroni:
P <0.0001).
Figure 2 shows the percentage of patients of the three
groups who had normal BMD, osteopenia or osteoporosis,
evaluated both at the femoral neck and at the lumbar
spine. The frequency of osteopenia and osteoporosis in-
creased from IBS to NCWS, and to CD patients (P <0.0001,
Spearman’s rank correlation). Osteopenia or osteoporosis
was found in 28% of the NCWS patients at the femoral
neck and in 34% at the lumbar spine, whereas only 6%
(lumbar spine) to 8% (femoral neck) of IBS patients had
osteopenia and none of them had osteoporosis (for femoral
neck P <0.02, chi-square 7.8; for lumbar spine P <0.001,
chi-square 13). In total, 35 NCWS patients (46.6%) had
osteopenia or osteoporosis at one of the two sites (femoral
neck or lumbar spine). CD patients had a higher fre-
quency of osteopenia (50%) and osteoporosis (14%) than
both NCWS and IBS patients.
Table 2 shows the frequency of some clinical, histo-
logical and genetic findings in the NCWS patients with
and without reduced BMD. In patients with NCWS and
osteopenia or osteoporosis, in comparison to the pa-
tients with normal BMD, there was a significantly
higher frequency of subjects with BMI values <20
(Mantel-Haenszel = 5.7, P <0.02), and with hemoglobin
values <12 gr/dl (Mantel-Haenszel = 10.1, P <0.001),
and of subjects with multiple food sensitivity (Mantel-Haenszel = 7.8, P <0.005). The presence of osteopenia
and osteoporosis did not correlate with the duodenal
histology findings (Marsh 0 or Marsh 1 and presence/
absence of eosinophil infiltration), nor with the pres-
ence of the DQ2 or DQ8 alleles, or with the serum
level of albumin and triglycerides (data not shown).
Furthermore, in NCWS patients, there was a signifi-
cant direct correlation between the individual values of
BMD (g/cm2) and the BMI values (P <0.0001) (Figure 3).
A similar, although less significant, correlation between
BMD and BMI values was also found in IBS patients
(r = 0.30, P <0.04) and in CD controls (r = 0.36, P <0.01).
Multiple regression analysis showed that the presence
of osteopenia or osteoporosis was related exclusively
to the BMI (P <0.002) and to multiple food sensitivity
(P <0.03).
Mean values ± SD of daily dietary calcium intake in
NCWS patients (considered as a group) were 615 ±
274 mg, significantly lower than in IBS controls (766 ±
284 mg; P <0.001) and in CD controls (821 ± 312 mg;
Figure 2 Percentage of the patients of the three groups who had normal BMD, osteopenia or osteoporosis, evaluated both at the
lumbar spine and femoral neck. The frequency of osteopenia and osteoporosis was significantly different in the three groups, increasing from
IBS to NCWS, and to CD patients (P <0.0001, Spearman’s rank correlation). BMD, bone mass density; CD, celiac disease; IBS, irritable bowel
syndrome; NCWS, non-celiac wheat sensitivity.
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tients with NCWS alone (calcium intake: median 770 mg/
daily, range 300 to 1100 mg) and those with multiple food
sensitivity (median 330 mg/daily, range 30 to 900 mg)
(z = 28.8, P <0.0001, Mann–Whitney test).
Wheat exclusion from the diet before entering the
study was self-reported in 21 of the 35 (60%) NCWS pa-
tients with osteopenia/osteoporosis and in 16 of the 40
(40%) patients without it (P <0.08, chi-square test).
There was no difference in smoking habits or the levels
of physical activity between the NCWS and IBS groups
or within the NCWS group in the subjects with bone
mass loss and those with normal bone mass.Discussion
An increasing number of papers have recently been
published by many groups which seemed to confirm that
‘gluten-sensitivity’ should definitely be included in the
spectrum of gluten-related disorders [2,3]. However,
some doubts persist about the pathogenic mechanisms
[9] and it has been suggested that wheat could cause
gastrointestinal symptoms independently of its gluten-Table 2 Distribution of some variables in NCWS patients with
osteoporosis
BMI <20 Hb <12 DQ2/DQ8
Normal n = 40 19 (47%) 2 (5%) 22 (55%)
Osteopenia n = 29 17 (59%) 7 (24%) 4 (14%)
Osteoporosis n = 6 6 (100%) 3 (50%) 5 (83%)
MI: χ2t = 5.7, P <0.02; Hb: χ2t = 10.1, P <0.001; multiple food sensitivity: χ2t = 7.8, P <
eosinophils: χ2t = 2.5, P = ns. Duodenal lymphocytosis (Marsh 1) was defined as a nu
was defined as a number of eosinophils >60 per 10 high-power fields. BMI, body m
wheat sensitivity, MFS, multiple food sensitivity.content [10-13]. For these reasons we suggested the
term ‘non-celiac wheat-sensitivity’ [14].
A recent UK study showed that the self-reported
prevalence of wheat-sensitivity was 13% [15]. The
prevalence of strict adherence to a gluten-free diet
in the general population ranged between 0.55 and
3.7% [15,16].
However, nothing is known about the osteoporotic risk
in this condition, whereas it is known that more than
75% of untreated celiac patients suffer from a loss of
bone mass [1].
We showed that the NCWS patients had a signifi-
cantly lower bone mineral content than IBS controls
both at the lumbar spine and at the femoral neck.
Furthermore, 35 of the 75 NCWS patients (46.6%) had
osteopenia or osteoporosis at one of the two sites. This
high frequency of low bone mass in NCWS patients
is much more relevant if it is considered that our
study population included young subjects, mostly pre-
menopausal women, with median age 36 years. These
women will reach the age of menopause - the most
critical period for bone loss risk - with bone mass
already reduced.normal bone density, with osteopenia and with
Marsh 1 Duodenal eosinophils MFS
24 (60%) 15 (37%) 10 (25%)
12 (41%) 9 (31%) 16 (55%)
3 (50%) 0 (0%) 4 (67%)
0.005; HLA DQ2/DQ8: χ2t = 1.2, P = ns; Marsh 1: χ2t = 1.4, P = ns; Duodenal
mber of CD3+ >25 IEL/100 epithelial cells. Duodenal eosinophils infiltration
ass index; Hb, hemoglobin; IEL, intraepithelial lymphocytes; NCWS, non-celiac
Figure 3 Individual values of BMD, expressed as absolute values (g/cm2), in relation to the BMI, both at the femoral neck (Panel a) and
at the lumbar spine (Panel b). A significant direct correlation between the individual values of BMD (g/cm2) and the BMI values (P <0.0001) has
been proved. BMD, bone mass density; BMI, body mass index.
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porosis in NCWS, we did not find any correlation with
the degree of inflammation of the duodenal mucosa:
there was no association with the Marsh 1 lesion (in-
creased number of IELs) nor with the mucosal eosino-
phil infiltrate. The presence of the DQ2 or DQ8 HLA
haplotypes was not associated with the presence of bone
mass loss. On the whole these data seem to indicate that
the mechanisms which cause osteoporosis in CD pa-
tients (malabsorption, inflammation, and so on) would
not be pivotal in NCWS patients.
On the contrary, we found a direct correlation of bone
mass loss with the BMI and hemoglobin values and these
data could support the hypothesis of a role for malnutrition.
In particular, it must be emphasized that about one third of
our patient population reported weight loss of >10% ofbody weight during the last year, and that 42 NCWS pa-
tients (56%) had a BMI less than 20. Thus, the role of mal-
nutrition seems very important in our study group.
We found that the dietary calcium intake of the
NCWS patients (mean 615 mg/day) was significantly
lower than that of the IBS controls, and much lower
than the 1,000 mg/day commonly recommended. The
selective malnutrition could be caused by self-restriction
of the diet: 37 of the 75 NCWS patients reported self-
exclusion of wheat before entering the study, and dietary
calcium intake was significantly lower in patients with
multiple food sensitivity than in patients with NCWS
alone, probably because the latter patients excluded a
higher number of foods from their diet. Bucci et al.
reported 70% of NCWS patients excluded milk and dairy
products from their diets to avoid symptoms [17];
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as ‘wheat-sensitives’ had additional food avoidances in-
cluding dairy (59%) [18]. A lower percentage (35%) of
coexistent food intolerance has been recently reported
in an Italian multicenter study [19]. This suggests that
NCWS patients need dietary support to avoid mineral or
other nutrient deficiencies.
However, the limits of our study must be highlighted.
We did not suggest a low fermentable oligo-di-mono-sac-
charides and polyols (FODMAPs) diet to our patients, and
it has been demonstrated that there was no evidence of ef-
fect of gluten in patients with gluten-sensitivity placed on
diets low in FODMAP [13]. However, our patients became
asymptomatic on the elimination diet and clearly reacted
on DBPC wheat challenge, performed with a relatively
small challenge dose of wheat. It is unlikely that our chal-
lenge method permitted us to identify many patients who
are intolerant of the carbohydrate content of wheat, spe-
cifically fructans. Consequently, it is probable that we have
studied a selected population which was different from
that reported by Biesiekierski et al. [13]. Thus, our finding
of the high prevalence of reduced bone mass and low BMI
in NCGS patients must not be generalized.
We found a very high percentage of malnourished pa-
tients in our study group, but eating disorders were not
regularly excluded by means of psychometric methods.
In any case, the high percentage of NCWS patients with
low BMI in our series could have influenced the high
frequency of low BMD we found.
Furthermore, we cannot exclude that a percentage of
our patients were in a ‘pre-celiac condition’, as could be
suggested by the presence of DQ2/DQ8 haplotypes
(41%), CD family history (24%) and duodenal lymphocy-
tosis (52%). However, these are common findings in the
NCWS population [2].
We were unable to provide data about Vitamin D
levels, parathyroid hormone and markers of both bone
synthesis and re-absorption; future studies need to clar-
ify the possible mechanisms of osteoporosis in NCWS.Conclusions
We found an elevated frequency of bone mass loss in
NCWS patients (46.6%). This was related to low BMI and
was more frequent in patients with NCWS associated with
other food sensitivity than in patients with NCWS alone.
Dietary support should be strongly recommended at the
time of NCWS diagnosis, whatever is its pathogenesis.Additional files
Additional file 1: Methods and diagnostic criteria in NCWS diagnosis.
Additional file 2: Number of patients included/excluded during the
different phases of the study.Additional file 3: VAS score comparison in patients suffering from
wheat sensitivity alone (GROUP 1) and patients suffering from
multiple food hypersensitivity (GROUP 2), under challenge with
wheat, cow milk and placebo.
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